Related Experiment Video
Updated: Jul 5, 2025

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
Anti-Aging Drugs and the Related Signal Pathways
Nannan Du1,2, Ruigang Yang1,2,3, Shengrong Jiang4
1Frontier Biotechnology Laboratory, Beijing Institute of Biotechnology, Beijing 100071, China.
Abstract:
Aging is a multifactorial biological process involving chronic diseases that manifest from the molecular level to the systemic level. From its inception to 31 May 2022, this study searched the PubMed, Web of Science, EBSCO, and Cochrane library databases to identify relevant research from 15,983 articles. Multiple approaches have been employed to combat aging, such as dietary restriction (DR), exercise, exchanging circulating factors, gene therapy, and anti-aging drugs. Among them, anti-aging drugs are advantageous in their ease of adherence and wide prevalence. Despite a shared functional output of aging alleviation, the current anti-aging drugs target different signal pathways that frequently cross-talk with each other. At present, six important signal pathways were identified as being critical in the aging process, including pathways for the mechanistic target of rapamycin (mTOR), AMP-activated protein kinase (AMPK), nutrient signal pathway, silent information regulator factor 2-related enzyme 1 (SIRT1), regulation of telomere length and glycogen synthase kinase-3 (GSK-3), and energy metabolism. These signal pathways could be targeted by many anti-aging drugs, with the corresponding representatives of rapamycin, metformin, acarbose, nicotinamide adenine dinucleotide (NAD+), lithium, and nonsteroidal anti-inflammatory drugs (NSAIDs), respectively. This review summarized these important aging-related signal pathways and their representative targeting drugs in attempts to obtain insights into and promote the development of mechanism-based anti-aging strategies.
Insights
This review explores key aging pathways and drugs targeting them. It highlights how drugs like rapamycin and metformin offer accessible strategies for aging alleviation and mechanism-based interventions.
Area of Science:
- Gerontology and molecular biology
- Focuses on the biological mechanisms of aging and therapeutic interventions.
Background:
- Aging is a complex process linked to chronic diseases, affecting individuals from molecular to systemic levels.
- Various interventions exist, including dietary changes, exercise, and pharmaceuticals, with anti-aging drugs offering ease of use and accessibility.
Purpose of the Study:
- To review critical aging-related signal pathways and their targeted drugs.
- To provide insights for developing mechanism-based anti-aging strategies.
Main Methods:
- Comprehensive literature search of PubMed, Web of Science, EBSCO, and Cochrane Library databases up to May 31, 2022.
- Identified 15,983 relevant articles for analysis.
Main Results:
- Six key aging pathways identified: mTOR, AMPK, nutrient signaling, SIRT1, telomere length regulation, and GSK-3/energy metabolism.
- Representative drugs targeting these pathways include rapamycin, metformin, acarbose, NAD+, lithium, and NSAIDs.
Conclusions:
- Anti-aging drugs targeting distinct pathways can alleviate aging.
- Understanding pathway crosstalk is crucial for advancing mechanism-based anti-aging therapies.
Related Concept Videos
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Signal Transduction: Overview
Typically, signal transduction involves three...
PI3K/mTOR/AKT Signaling Pathway
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

